Cargando…

Appropriate and timely antibiotic administration for neonatal sepsis in Mesoamérica

Neonatal sepsis is a leading cause of mortality among children under-5 in Latin America. The Salud Mesoamérica Initiative (SMI), a multicountry results-based aid programme, was designed to improve maternal, newborn and child health in impoverished communities in Mesoamérica. This study examines the...

Descripción completa

Detalles Bibliográficos
Autores principales: Duber, Herbert C, Hartford, Emily A, Schaefer, Alexandra M, Johanns, Casey K, Colombara, Danny V, Iriarte, Emma, Palmisano, Erin B, Rios-Zertuche, Diego, Zuniga-Brenes, Paola, Hernández-Prado, Bernardo, Mokdad, Ali H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5969725/
https://www.ncbi.nlm.nih.gov/pubmed/29862053
http://dx.doi.org/10.1136/bmjgh-2017-000650
_version_ 1783326002915573760
author Duber, Herbert C
Hartford, Emily A
Schaefer, Alexandra M
Johanns, Casey K
Colombara, Danny V
Iriarte, Emma
Palmisano, Erin B
Rios-Zertuche, Diego
Zuniga-Brenes, Paola
Hernández-Prado, Bernardo
Mokdad, Ali H
author_facet Duber, Herbert C
Hartford, Emily A
Schaefer, Alexandra M
Johanns, Casey K
Colombara, Danny V
Iriarte, Emma
Palmisano, Erin B
Rios-Zertuche, Diego
Zuniga-Brenes, Paola
Hernández-Prado, Bernardo
Mokdad, Ali H
author_sort Duber, Herbert C
collection PubMed
description Neonatal sepsis is a leading cause of mortality among children under-5 in Latin America. The Salud Mesoamérica Initiative (SMI), a multicountry results-based aid programme, was designed to improve maternal, newborn and child health in impoverished communities in Mesoamérica. This study examines the delivery of timely and appropriate antibiotics for neonatal sepsis among facilities participating in the SMI project. A multifaceted health facility survey was implemented at SMI inception and approximately 18 months later as a follow-up. A random sample of medical records from neonates diagnosed with sepsis was reviewed, and data regarding antibiotic administration were extracted. In this paper, we present the percentage of patients who received timely (within 2 hours) and appropriate antibiotics. Multilevel logistic regression was used to assess for potential facility-level determinants of timely and appropriate antibiotic treatment. Among 821 neonates diagnosed with sepsis in 63 facilities, 61.8% received an appropriate antibiotic regimen, most commonly ampicillin plus an aminoglycoside. Within 2 hours of presentation, 32.3% received any antibiotic and only 26.6% received an appropriate regimen within that time. Antibiotic availability improved over the course of the SMI project, increasing from 27.5% at baseline to 64.0% at follow-up, and it was highly correlated with timely and appropriate antibiotic administration (adjusted OR=5.36, 95% CI 2.85 to 10.08). However, we also found a decline in the percentage of neonates documented to have received appropriate antibiotics (74.4% vs 51.1%). Our study demonstrated early success of the SMI project through improvements in the availability of appropriate antibiotic regimens for neonatal sepsis. At the same time, overall rates of timely and appropriate antibiotic administration remain low, and the next phase of the initiative will need to address other barriers to the provision of life-saving antibiotic treatment for neonatal sepsis.
format Online
Article
Text
id pubmed-5969725
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-59697252018-06-01 Appropriate and timely antibiotic administration for neonatal sepsis in Mesoamérica Duber, Herbert C Hartford, Emily A Schaefer, Alexandra M Johanns, Casey K Colombara, Danny V Iriarte, Emma Palmisano, Erin B Rios-Zertuche, Diego Zuniga-Brenes, Paola Hernández-Prado, Bernardo Mokdad, Ali H BMJ Glob Health Research Neonatal sepsis is a leading cause of mortality among children under-5 in Latin America. The Salud Mesoamérica Initiative (SMI), a multicountry results-based aid programme, was designed to improve maternal, newborn and child health in impoverished communities in Mesoamérica. This study examines the delivery of timely and appropriate antibiotics for neonatal sepsis among facilities participating in the SMI project. A multifaceted health facility survey was implemented at SMI inception and approximately 18 months later as a follow-up. A random sample of medical records from neonates diagnosed with sepsis was reviewed, and data regarding antibiotic administration were extracted. In this paper, we present the percentage of patients who received timely (within 2 hours) and appropriate antibiotics. Multilevel logistic regression was used to assess for potential facility-level determinants of timely and appropriate antibiotic treatment. Among 821 neonates diagnosed with sepsis in 63 facilities, 61.8% received an appropriate antibiotic regimen, most commonly ampicillin plus an aminoglycoside. Within 2 hours of presentation, 32.3% received any antibiotic and only 26.6% received an appropriate regimen within that time. Antibiotic availability improved over the course of the SMI project, increasing from 27.5% at baseline to 64.0% at follow-up, and it was highly correlated with timely and appropriate antibiotic administration (adjusted OR=5.36, 95% CI 2.85 to 10.08). However, we also found a decline in the percentage of neonates documented to have received appropriate antibiotics (74.4% vs 51.1%). Our study demonstrated early success of the SMI project through improvements in the availability of appropriate antibiotic regimens for neonatal sepsis. At the same time, overall rates of timely and appropriate antibiotic administration remain low, and the next phase of the initiative will need to address other barriers to the provision of life-saving antibiotic treatment for neonatal sepsis. BMJ Publishing Group 2018-05-24 /pmc/articles/PMC5969725/ /pubmed/29862053 http://dx.doi.org/10.1136/bmjgh-2017-000650 Text en © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/
spellingShingle Research
Duber, Herbert C
Hartford, Emily A
Schaefer, Alexandra M
Johanns, Casey K
Colombara, Danny V
Iriarte, Emma
Palmisano, Erin B
Rios-Zertuche, Diego
Zuniga-Brenes, Paola
Hernández-Prado, Bernardo
Mokdad, Ali H
Appropriate and timely antibiotic administration for neonatal sepsis in Mesoamérica
title Appropriate and timely antibiotic administration for neonatal sepsis in Mesoamérica
title_full Appropriate and timely antibiotic administration for neonatal sepsis in Mesoamérica
title_fullStr Appropriate and timely antibiotic administration for neonatal sepsis in Mesoamérica
title_full_unstemmed Appropriate and timely antibiotic administration for neonatal sepsis in Mesoamérica
title_short Appropriate and timely antibiotic administration for neonatal sepsis in Mesoamérica
title_sort appropriate and timely antibiotic administration for neonatal sepsis in mesoamérica
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5969725/
https://www.ncbi.nlm.nih.gov/pubmed/29862053
http://dx.doi.org/10.1136/bmjgh-2017-000650
work_keys_str_mv AT duberherbertc appropriateandtimelyantibioticadministrationforneonatalsepsisinmesoamerica
AT hartfordemilya appropriateandtimelyantibioticadministrationforneonatalsepsisinmesoamerica
AT schaeferalexandram appropriateandtimelyantibioticadministrationforneonatalsepsisinmesoamerica
AT johannscaseyk appropriateandtimelyantibioticadministrationforneonatalsepsisinmesoamerica
AT colombaradannyv appropriateandtimelyantibioticadministrationforneonatalsepsisinmesoamerica
AT iriarteemma appropriateandtimelyantibioticadministrationforneonatalsepsisinmesoamerica
AT palmisanoerinb appropriateandtimelyantibioticadministrationforneonatalsepsisinmesoamerica
AT rioszertuchediego appropriateandtimelyantibioticadministrationforneonatalsepsisinmesoamerica
AT zunigabrenespaola appropriateandtimelyantibioticadministrationforneonatalsepsisinmesoamerica
AT hernandezpradobernardo appropriateandtimelyantibioticadministrationforneonatalsepsisinmesoamerica
AT mokdadalih appropriateandtimelyantibioticadministrationforneonatalsepsisinmesoamerica